Jinwon Life Sciences Signs Supply Contract Worth 2.1 Billion KRW with U.S. Biotech Company
[Asia Economy Reporter Lee Seon-ae] Jinwon Life Sciences announced on the 26th that it has signed a Plasmid DNA supply contract with a US biotech company.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Don't Throw Away Coffee Grounds" Transformed into 'High-Grade Fuel' in Just 90 Seconds [Reading Science]
- Signed Without Viewing for 1.6 Billion Won... Jamsil and Seongbuk Jeonse Prices Jump 200 Million Won in a Month [Real Estate AtoZ]
- "Groups of 5 or More Now Restricted"... Unrelenting Running Craze Leaves Citizens and Police Exhausted
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
The contract amount is 2,084.45 million KRW, which corresponds to 5.39% of the sales in 2021. The contract period is until April 30, 2023.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
